Your browser doesn't support javascript.
loading
Role of FNA with core biopsy or cell block in patients with nodular lymphocyte-predominant Hodgkin lymphoma.
Gupta, Srishti; Long, Steven R; Natkunam, Yasodha; Kong, Christina S; Gupta, Neel K; Gratzinger, Dita.
Afiliación
  • Gupta S; Department of Pathology, Stanford University School of Medicine, Stanford, California, USA.
  • Long SR; Department of Pathology, Stanford University School of Medicine, Stanford, California, USA.
  • Natkunam Y; Department of Pathology, Stanford University School of Medicine, Stanford, California, USA.
  • Kong CS; Department of Pathology, Stanford University School of Medicine, Stanford, California, USA.
  • Gupta NK; Division of Hematology Oncology, Stanford University School of Medicine, Stanford, California, USA.
  • Gratzinger D; Department of Pathology, Stanford University School of Medicine, Stanford, California, USA.
Cancer Cytopathol ; 128(8): 570-579, 2020 08.
Article en En | MEDLINE | ID: mdl-32343479
ABSTRACT

BACKGROUND:

Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) represents a diagnostic challenge on surgical excisional or incisional biopsy. Classification is further challenging on fine needle aspiration (FNA) material accompanied by needle core and/or cell block biopsy (FNA+core/CB).

METHODS:

The authors studied all FNA+core/CB and surgical excisional or incisional biopsies to evaluate for lymphoma in patients who had a prior history of NLPHL or subsequent diagnosis of NLPHL over a 5-year period from 2012 through 2016.

RESULTS:

Patients who ultimately were diagnosed with NLPHL represented <0.5% of those who underwent FNA+core/CB for an initial suspicion of lymphoma. FNA+core/CB resulted in a definitive diagnosis in 7 of 13 cases, and surgical excisional or incisional biopsy specimens resulted in a definitive diagnosis in 13 of 13 cases (chi-square statistic, 9.6; P = .002). At initial diagnosis, FNA+core/CB was negative in 2 cases and atypical or suspicious in 3 cases; all 5 of those patients required surgical excisional or incisional biopsy for a definitive lymphoma diagnosis. By contrast, patients who underwent FNA+core/CB for recurrent lymphoma required surgical excisional or incisional biopsy in only 1 of 8 cases (chi-square statistic, 9.5; P = .002). Flow cytometry was positive for a light-chain-restricted B-cell population in only 1 of 11 biopsies that were involved by lymphoma.

CONCLUSIONS:

Surgical excisional or incisional biopsy remains the gold standard for NLPHL diagnosis and for distinguishing progression to a T-cell/histiocyte-rich large B-cell lymphoma pattern. At a tertiary cancer center with routine collaborative diagnosis of lymphoma on FNA+core/CB by cytopathologists and hematopathologists, FNA+core/CB performs well to assess for recurrent or transformed NLPHL, rarely requiring subsequent surgical excisional or incisional biopsy. FNA+core/CB has limited sensitivity in the initial diagnosis setting.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Linfocitos B Límite: Adult / Aged / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Cytopathol Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Linfocitos B Límite: Adult / Aged / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Cytopathol Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos